ProKidney Corp. Profile Avatar - Palmy Investing

ProKidney Corp.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II cl…

Biotechnology
US, Winston-Salem [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PROK's Analysis
CIK: 1850270 CUSIP: - ISIN: KYG7S53R1049 LEI: - UEI: -
Secondary Listings
PROK has no secondary listings inside our databases.